Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-21-024288

Senior Vice President, Finance sold 22,500 shares at $35.00 ($787,500)

  • Senior Vice President, Finance acquired 22,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Senior Vice President, Finance 2021-03-30 Option exercise +22,500 $4.12 $92,700 22,500 D
Catinazzo Thomas Senior Vice President, Finance 2021-03-30 Sale −22,500 $35.00 $787,500 0 D
Derivatives
Catinazzo Thomas Senior Vice President, Finance 2021-03-30 Option exercise · Stock Option (Right to Buy) −22,500 107,043 D
Open-market sales · 22,500 sh · avg $35.00 · $787,500
Loading xslF345X03/doc4.xml…